Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1994-04-28
1996-08-13
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
A61K 3119, A61K 31557
Patent
active
055456715
ABSTRACT:
The invention relates to an antimetastatically acting agent consisting of Eptaloprost, Cicaprost or combinations of TXA.sub.2 antagonist and prostacyclin derivatives.
REFERENCES:
Advances in Prostaglandin, Thromboxane; and Leukotriene Research, vol. 21B, prostaglandins and Related Compounds, Seventh International Conference, Florence, Italy, 1990, pp. 913-916, Giraldi et al., "Antimetastatic action of stable prostacyclin analogs in mice".
Advances in Prostaglandin Thromboxane, and Leukotriene Research, vol. 21B Prostaglandins and Related Compounds, Seventh International Conference, Florence, Italy, 1990, pp. 901-908, Schneider et al., "Effects of prostacyclin analogues in in vivo tumor models".
European Search Report of Feb. 19, 1992 for Appln. No. EP 90 25 0257.
Communication in Intenatinal PCT Appln. PCT/EP 90/01676; International Filing Date: Oct. 5, 1990.
Schillinger Ekkehard
Schneider Martin
Goldberg Jerome D.
Schering Aktiengesellschaft
LandOfFree
Antimetastically acting agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antimetastically acting agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antimetastically acting agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1048297